Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis
暂无分享,去创建一个
C. Uyttenhove | A. Yoshimura | G. Pasterkamp | J. Van Snick | A. Tedgui | Z. Mallat | B. Esposito | B. Ramkhelawon | S. Taleb | H. Yasukawa | Melissa A Romain | Olivier Herbin | Nicolas Pérez | Bhama Ramkhelawon
[1] J. Egido,et al. Suppressors of Cytokine Signaling Modulate JAK/STAT-Mediated Cell Responses During Atherosclerosis , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[2] J. Pober,et al. Interleukin-17 and Interferon-γ Are Produced Concomitantly by Human Coronary Artery–Infiltrating T Cells and Act Synergistically on Vascular Smooth Muscle Cells , 2009, Circulation.
[3] P. Libby,et al. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models , 2008, Nature Reviews Immunology.
[4] L. Joosten,et al. IL-17 produced by Paneth cells drives TNF-induced shock , 2008 .
[5] S. Tangye,et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3 , 2008, The Journal of experimental medicine.
[6] D. Riethmacher,et al. In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORγt+ T cells , 2008, The Journal of experimental medicine.
[7] Chen Dong,et al. TH17 cells in development: an updated view of their molecular identity and genetic programming , 2008, Nature Reviews Immunology.
[8] W. Paul,et al. Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome , 2008, Nature.
[9] A. Yoshimura,et al. Loss of Suppressor of Cytokine Signaling 1 in Helper T Cells Leads to Defective Th17 Differentiation by Enhancing Antagonistic Effects of IFN-γ on STAT3 and Smads1 , 2008, The Journal of Immunology.
[10] ZiadMallat,et al. Defective Leptin/Leptin Receptor Signaling Improves Regulatory T Cell Immune Response and Protects Mice From Atherosclerosis , 2007 .
[11] F. Moll,et al. Intraobserver and interobserver variability and spatial differences in histologic examination of carotid endarterectomy specimens. , 2007, Journal of vascular surgery.
[12] K. Clément,et al. Defective Leptin/Leptin Receptor Signaling Improves Regulatory T Cell Immune Response and Protects Mice From Atherosclerosis , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[13] M. Fishbein,et al. Role of the JAK/STAT Pathway in the Regulation of Interleukin-8 Transcription by Oxidized Phospholipids in Vitro and in Atherosclerosis in Vivo* , 2007, Journal of Biological Chemistry.
[14] C. Uyttenhove,et al. Anti‐IL‐17A Autovaccination Prevents Clinical and Histological Manifestations of Experimental Autoimmune Encephalomyelitis , 2007, Annals of the New York Academy of Sciences.
[15] Masato Kubo,et al. SOCS proteins, cytokine signalling and immune regulation , 2007, Nature Reviews Immunology.
[16] S. Holland,et al. Causes of death in hyper-IgE syndrome. , 2007, The Journal of allergy and clinical immunology.
[17] V. Kuchroo,et al. TH-17 cells in the circle of immunity and autoimmunity , 2007, Nature Immunology.
[18] A. Arai,et al. Coronary artery aneurysms in patients with hyper IgE recurrent infection syndrome. , 2007, Clinical immunology.
[19] B. Ryffel,et al. Interleukin-17 is a negative regulator of established allergic asthma , 2006, The Journal of experimental medicine.
[20] C. Uyttenhove,et al. Development of an anti‐IL‐17A auto‐vaccine that prevents experimental auto‐immune encephalomyelitis , 2006, European journal of immunology.
[21] Peter Libby,et al. The immune response in atherosclerosis: a double-edged sword , 2006, Nature Reviews Immunology.
[22] M. Netea,et al. Critical aneurysmal dilatation of the thoracic aorta in young adolescents with variant hyperimmunoglobulin E syndrome , 2006, Journal of internal medicine.
[23] L. Hennighausen,et al. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[24] Satoru Fukuyama,et al. Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor–β1 , 2006, The Journal of experimental medicine.
[25] A. Tedgui,et al. Cytokines in atherosclerosis: pathogenic and regulatory pathways. , 2006, Physiological reviews.
[26] C. Betsholtz,et al. The absence of platelet-derived growth factor-B in circulating cells promotes immune and inflammatory responses in atherosclerosis-prone ApoE-/- mice. , 2005, The American journal of pathology.
[27] A. Tedgui,et al. Age and gender effects on apoptosis in the human coronary arterial wall , 2005, Mechanisms of Ageing and Development.
[28] A. Tedgui,et al. Induction of a Regulatory T Cell Type 1 Response Reduces the Development of Atherosclerosis in Apolipoprotein E–Knockout Mice , 2003, Circulation.
[29] S. Akira,et al. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages , 2003, Nature Immunology.
[30] J. Johnston,et al. SOCS-3 regulates onset and maintenance of TH2-mediated allergic responses , 2003, Nature Medicine.
[31] J. Witztum,et al. Innate and acquired immunity in atherogenesis , 2002, Nature Medicine.
[32] P. Libby,et al. Mucosal Administration of Heat Shock Protein-65 Decreases Atherosclerosis and Inflammation in Aortic Arch of Low-Density Lipoprotein Receptor-Deficient Mice , 2002, Circulation.
[33] Keith C. Norris,et al. The Healthy Community Neighborhood Initiative: Rationale and Design. , 2016, Ethnicity & disease.
[34] F. Moll,et al. The Mollring Cutter™ Remote Endarterectomy: Preliminary Experience with a New Endovascular Technique for Treatment of Occlusive Superficial Femoral Artery Disease , 1995, Journal of endovascular surgery : the official journal of the International Society for Endovascular Surgery.
[35] G. Galbraith. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome , 2008 .
[36] S. Tangye,et al. Defi ciency of Th 17 cells in hyper IgE syndrome due to mutations in STAT 3 Cindy , 2008 .
[37] M. Daemen,et al. Atherosclerosis in Mice Lactadherin Deficiency Leads to Apoptotic Cell Accumulation and Accelerated , 2007 .
[38] Lai Wei,et al. Role of the JAK/STAT Pathway in the Regulation of IL-8 Transcription by Oxidized Phospholipids in vitro and in Atherosclerosis in vivo , 2007 .
[39] G. Pasterkamp,et al. Athero-express: Differential atherosclerotic plaque expression of mRNA and protein in relation to cardiovascular events and patient characteristics. Rationale and design , 2004, European Journal of Epidemiology.
[40] Hua Yu,et al. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells , 2004, Nature Medicine.